Human cytosolic sialidase NEU2-low general tissue expression but involvement in PC-3 prostate cancer cell survival

Biochemical and Biophysical Research Communications

Volumn 428, Issue 1, 2012, Pages 142-149

  Koseki, Koichi ^a   Wada, Tadashi ^b   Hosono, Masahiro ^b   Hata, Keiko ^b   Yamaguchi, Kazunori ^a   Nitta, Kazuo ^b   Miyagi, Taeko ^a,b  

^a MIYAGI CANCER CENTER RESEARCH INSTITUTE   (Japan)

^b TOHOKU PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Cell survival; NEU2 expression; PC 3 cells; Runx2; Sialidase; Sp3

Indexed keywords

COMPLEMENTARY DNA; MESSENGER RNA; PROTEIN; PROTEIN NEU 2; SIALIDASE; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR RUNX2; TRANSCRIPTION FACTOR SP3; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BINDING SITE; CELL MOTILITY; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; CYTOSOL; GENE EXPRESSION PROFILING; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; PLACENTA; PRIORITY JOURNAL; PROMOTER REGION; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM; TESTIS;

CELL LINE, TUMOR; CELL SURVIVAL; CORE BINDING FACTOR ALPHA 1 SUBUNIT; CYTOSOL; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; NEURAMINIDASE; PROMOTER REGIONS, GENETIC; PROSTATIC NEOPLASMS; RNA, SMALL INTERFERING; SP3 TRANSCRIPTION FACTOR; TISSUE DISTRIBUTION;

EID: 84868365573     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.10.028     Document Type: Article

References (32)

1. Monti E., Bonten E., D'Azzo A., Bresciani R., Venerando B., Borsani G., Schauer R., Tettamanti G. Sialidases in vertebrates: a family of enzymes tailored for several cell functions. Adv. Carbohydr. Chem. Biochem. 2010, 64:403-479.
2. Miyagi T., Yamaguchi K. Mammalian sialidases: physiological and pathological roles in cellular functions. Glycobiology 2012, 22:880-896.
3. Miyagi T., Konno K., Emori Y., Kawasaki H., Suzuki K., Yasui A., Tsuiki S. Molecular cloning and expression of cDNA encoding rat skeletal muscle cytosolic sialidase. J. Biol. Chem. 1993, 268:26435-26440.
4. Sato K., Miyagi T. Genomic organization and the 5'-upstream sequence of the rat cytosolic sialidase gene. Glycobiology 1995, 5:511-516.
5. Ferrari J., Harris R., Warner T.G. Cloning and expression of a soluble sialidase from Chinese hamster ovary cells: sequence alignment similarities to bacterial sialidases. Glycobiology 1994, 4:367-373.
6. Kotani K., Kuroiwa A., Saito T., Matsuda Y., Koda T., Kijimoto-Ochiai S. Cloning, chromosomal mapping, and characteristic 5'-UTR sequence of murine cytosolic sialidase. Biochem. Biophys. Res. Commun. 2001, 286:250-258.
7. Monti E., Preti A., Rossi E., Ballabio A., Borsani G. Cloning and characterization of NEU2, a human gene homologous to rodent soluble sialidases. Genomics 1999, 57:137-143.
8. Monti E., Preti A., Nesti C., Ballabio A., Borsani G. Expression of a novel human sialidase encoded by the NEU2 gene. Glycobiology 1999, 9:1313-1321.
9. Sato K., Miyagi T. Involvement of an endogenous sialidse in skeletal muscle cell differentiation. Biochem. Biophys. Res. Commun. 1996, 221:826-830.
10. Fanzani A., Giuliani R., Colombo F., Zizioli D., Presta M., Preti A., Marchesini S. Overexpression of cytosolic sialidase Neu2 induces myoblast differentiation in C2C12 cells. FEBS Lett. 2003, 547:183-188.
11. Fanzani A., Colombo F., Giuliani R., Preti A., Marchesini S. Cytosolic sialidase Neu2 upregulation during PC12 cells differentiation. FEBS Lett. 2004, 566:178-182.
12. Tokuyama S., Moriya S., Taniguchi S., Yasui A., Miyazaki J., Orikasa S., Miyagi T. Suppression of pulmonary metastasis in murine B16 melanoma cells by transfection of a sialidase cDNA. Int. J. Cancer 1997, 73:410-415.
13. Sawada M., Moriya S., Saito S., Shineha R., Satomi S., Yamori T., Tsuruo T., Kannagi R., Miyagi T. Reduced sialidase expression in highly metastatic variants of mouse colon adenocarcinoma 26 and retardation of their metastatic ability by sialidase overexpression. Int. J. Cancer 2002, 97:180-185.
14. Fanzani A., Colombo F., Giuliani R., Preti A., Marchesini S. Insulin-like growth factor 1 signaling regulates cytosolic sialidase Neu2 expression during myoblast differentiation and hypertrophy. FEBS J. 2006, 273:3709-3721.
15. Fanzani A., Giuliani R., Colombo F., Rossi S., Stoppani E., Martinet W., Preti A., Marchesini S. The enzymatic activity of sialidase Neu2 is inversely regulated during in vitro myoblast hypertrophy and atrophy. Biochem. Biophys. Res. Commun. 2008, 370:376-381.
16. Tringali C., Papini N., Fusi P., Croci G., Borsani G., Preti A., Tortora P., Tettamanti G., Venerando B., Monti E. Properties of recombinant human cytosolic sialidase HsNEU2. J. Biol. Chem. 2004, 279:3169-3179.
17. Chavas L.M.G., Tringali C., Fusi P., Venerando B., Tettamanti G., Kato R., Monti E., Wakatsuki S. Crystal structure of the human cytosolic sialidase Neu2. J. Biol. Chem. 2005, 280:469-475.
18. Tringali C., Lupo B., Anastasia L., Papini N., Monti E., Bresciani R., Tettamanti G., Venerando B. Expression of sialidase Neu2 in Leukemic K562 cells induces apoptosis by impairing Bcr-Abl/Src kinases signaling. J. Biol. Chem. 2007, 282:14364-14372.
19. Yamaguchi K., Hata K., Koseki K., Shiozaki K., Akita H., Wada T., Moriya S., Miyagi T. Evidence for mitochondrial localization of a novel human sialidase (NEU4). Biochem. J. 2005, 390:85-93.
20. Hata K., Koseki K., Yamaguchi K., Moriya S., Suzuki Y., Yingsakmongkon S., Hirai G., Sodeoka M., von Itzstein M., Miyagi T. Limited inhibitory effects of oseltamivir and zanamivir on human sialidases. Antimicrob. Agents Chemother. 2008, 52:3484-3491.
21. Li C.Y., Yu Q., Ye Z.Q., Sun Y., He Q., Li X.M., Zhang W., Luo J., Gu X., Zheng X., Wei L. A nonsynonymous SNP in human cytosolic sialidase in a small Asian population results in reduced enzyme activity: potential link with severe adverse reactions to oseltamivir. Cell Res. 2007, 17:357-362.
22. Miyagi T., Takahashi K., Hata K., Shiozaki K., Yamaguchi K. Sialidase significance for cancer progression. Glycoconjugate J 2012, 29:567-577.
23. Y. Akiyama, TFSEARCH: searching transcription factor binding sites http://mbs.cbrc.jp/research/db/TFSEARCH.html.
24. Ueno K., Ishizuka I., Yamakawa T. Glycolipid composition of human testis at different ages and the stereochemical configuration of seminolipid. Biochim. Biophys. Acta 1977, 487:61-73.
25. Taki T., Matsuo K., Yamamoto K., Matsubara T., Hayashi A., Abe T., Matsumoto M. Human placenta gangliosides. Lipids 1988, 23:192-198.
26. Andreasian G.O., Malykh I., Diatlovitskaia E.V. Ceramides and gangliosides in benign and malignant human ovarian tumors. Vopr. Med. Khim. 1996, 42:248-253.
27. Ishizuka A., Hashimto Y., Naka R., Kinoshita M., Kakehi K., Seino J., Funakoshi Y., Suzuki T., Kameyama A., Narimatsu H. Accumulation of free complex-type N-glycans in MKN7 and MKN45 stomach cancer cells. Biochem. J. 2008, 413:227-237.
28. Komori T. Regulation of osteoblast differentiation by transcription factors. J. Cellular Biochem. 2006, 99:1233-1239.
29. Cher M.L., Towler D.A., Rafii S., Rowley D., Donahue H.J., Keller E., Herlyn M., Cho E.A., Chung L.W.K. Cancer interaction with the bone microenvironment. Am. J. Pathol. 2006, 168:1405-1412.
30. Suske G. The Sp-family of transcription factors. Gene 1999, 238:291-300.
31. Kaczynski J., Cook T., Urrutia R. Sp1- and Kruppel-like transcription factors. Genome Biol. 2003, 4:206.1-206.8. reviews.
32. Gollner H., Dani C., Phillips B., Philipsen S., Suske G. Impaired ossification in mice lacking the transcription factor Sp3. Mech. Dev. 2001, 106:77-83.